Article

Alimera, CYNACON align for lid scrub family

Atlanta-Alimera Sciences Inc. sales representatives will provide details and samples of the OCuSOFT lid scrub family of eyelid cleansers to existing ophthalmic and optometric customers as part of a co-promotion agreement with CYNACON/OCuSOFT.

Atlanta-Alimera Sciences Inc. sales representatives will provide details and samples of the OCuSOFT lid scrub family of eyelid cleansers to existing ophthalmic and optometric customers as part of a co-promotion agreement with CYNACON/OCuSOFT.

"This agreement matches Alimera Sciences' excellent practitioner relationships with CYNACON/OCuSOFT's quality product line," said Dan Myers, Alimera Sciences' chief executive officer. "OCuSOFT Lid Scrub is the number-one doctor-recommended eyelid cleanser, and we expect this collaboration to provide expanded care to doctors and staff as well as their patients."

"We could not be more excited about this partnership," said Cynthia L. Barratt, president and chief executive officer for CYNACON/OCuSOFT, Richmond, TX. "The entire executive staff at Alimera has prior experience managing a national campaign for another brand in the eyelid hygiene category. Collectively, we now have not only the number-one brand, but a strong, experienced management team as well."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.